ethosuximide has been researched along with Central Nervous System Origin Vertigo in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kästner, I | 1 |
| Roth, N | 1 |
1 trial available for ethosuximide and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[Effect of ethosuximide on the activity and psychomotor performance of healthy individuals].
Topics: Adult; Clinical Trials as Topic; Drug Evaluation; Electrocardiography; Electroencephalography; Ethos | 1974 |